Sie sind auf Seite 1von 2

Name of Drug TRANEXAMIC ACID

Classification Antihemorrhagic, Antifibrinolytic

Action Interferes with plasminogen activator substances and blocks action of fibrinolysin(plasmin)

Contraindications >Hypersensitivity to drug >Upper urinary tract bleeding >Disseminated intravascular coagulation >Neonates(injectable form)

Adverse Effect CNS: dizziness, malaise, headache, delirium, hallucinations, weakness, seizures CV: hypotension, ischemia, thrombophlebitis, cardiomyopathy, bradycardia, arrythmias EENT: conjunctival suffusion, tinnitus, nasal congestion GI: nausea, vomiting, diarrhea, abdominal pain, dyspepsia GU: intrarenal obstruction, renal failure Hemetologic: bleeding tendency, generalized thrombosis, agranulocytosis, leucopenia, thrombocytopenia Muskuloskeletal:

Nursing Responsibility Patient monitoring: >monitor V/S, fluid intake and output, and ECG >Assess for signs and symptoms of thrombophlebitis and pulmonary embolism >Monitor neurologic status, especially for signs of impending seizure >Monitor kidney and liver function test results, serum electrolytes level, and CBC with white cell differential >Evaluate for blood dyscrasias, particularly bleeding tendencies

myopathy, rabdomyolysis Respiratory: dyspnea, pulmonaryembolism Skin: rash, pruritus

Das könnte Ihnen auch gefallen